Clinical Trial Update: A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

View source ↗

Summary

A Gilead registry update describing outcomes for subjects who did not achieve sustained virologic response in chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C, Chronic | Status: COMPLETED